Renalytix’s US IPO filing document went live overnight (having previously been filed confidentially). Whilst there are no details on size of offering, but the document is rich with details of the use of proceeds which we encourage UK investors to read. We are doing the same and will update our views in due course. Associated with the US filing document, another release this morning announces the publication of a circular, and outlines details for a new General Meeting on the 13 July 2020 to appr ....
25 Jun 2020
US IPO filing document and board changes
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
US IPO filing document and board changes
Renalytix Plc (RENX:LON) | 30.0 0 0.0% | Mkt Cap: 37.9m
- Published:
25 Jun 2020 -
Author:
Edward Thomason -
Pages:
3
Renalytix’s US IPO filing document went live overnight (having previously been filed confidentially). Whilst there are no details on size of offering, but the document is rich with details of the use of proceeds which we encourage UK investors to read. We are doing the same and will update our views in due course. Associated with the US filing document, another release this morning announces the publication of a circular, and outlines details for a new General Meeting on the 13 July 2020 to appr ....